Humana Inc. (NYSE:HUM) Shares Bought by AM Squared Ltd

AM Squared Ltd lifted its position in Humana Inc. (NYSE:HUM) by 200.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 300 shares of the insurance provider’s stock after acquiring an additional 200 shares during the period. AM Squared Ltd’s holdings in Humana were worth $95,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the company. Mutual of America Capital Management LLC increased its position in shares of Humana by 12.4% in the third quarter. Mutual of America Capital Management LLC now owns 21,717 shares of the insurance provider’s stock worth $6,879,000 after acquiring an additional 2,395 shares in the last quarter. Kinsale Capital Group Inc. increased its position in shares of Humana by 21.2% in the third quarter. Kinsale Capital Group Inc. now owns 11,777 shares of the insurance provider’s stock worth $3,730,000 after acquiring an additional 2,062 shares in the last quarter. Natixis Advisors LLC increased its position in shares of Humana by 1.1% in the third quarter. Natixis Advisors LLC now owns 96,375 shares of the insurance provider’s stock worth $30,526,000 after acquiring an additional 1,023 shares in the last quarter. Mizuho Securities USA LLC increased its position in shares of Humana by 914.2% in the third quarter. Mizuho Securities USA LLC now owns 94,183 shares of the insurance provider’s stock worth $29,832,000 after acquiring an additional 84,897 shares in the last quarter. Finally, Empowered Funds LLC increased its position in shares of Humana by 164.0% in the third quarter. Empowered Funds LLC now owns 14,914 shares of the insurance provider’s stock worth $4,724,000 after acquiring an additional 9,264 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research analysts have recently weighed in on the stock. Barclays lifted their target price on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 31st. Wells Fargo & Company decreased their price target on shares of Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a report on Monday, November 4th. KeyCorp started coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating for the company. TD Cowen raised their price target on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Leerink Partners cut shares of Humana from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from $400.00 to $250.00 in a report on Wednesday, October 2nd. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $315.86.

Humana Price Performance

Shares of Humana stock opened at $275.67 on Friday. The firm has a fifty day simple moving average of $281.36 and a 200-day simple moving average of $331.81. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $527.18. The stock has a market capitalization of $33.19 billion, a price-to-earnings ratio of 24.42, a PEG ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The business had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. On average, sell-side analysts expect that Humana Inc. will post 15.86 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.28%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is currently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.